Jeffrey Nau, Founder of Aviceda Therapeutics

Jeffrey Nau is the founder of Aviceda Therapeutics. Aviceda Therapeutics has raised $210M, latest Series C $210M (2025). Biotech · Cambridge, MA.

About Jeffrey Nau

Jeffrey Nau is the founder of Aviceda Therapeutics. Aviceda Therapeutics operates in Biotech and is based in Cambridge, MA. Aviceda Therapeutics has raised $210M, latest Series C $210M (2025). Backers on record include Arsani William, Graham Walmsley, Logos Capital.

Jeffrey Nau at a glance

Company
Aviceda Therapeutics
Industry
Biotech
Location
Cambridge, MA
Total raised
$210M
Investors on record
Arsani William, Graham Walmsley, Logos Capital

Frequently asked about Jeffrey Nau

Who is Jeffrey Nau?
Jeffrey Nau is the founder of Aviceda Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Jeffrey Nau found?
Jeffrey Nau founded Aviceda Therapeutics, a Biotech company based in Cambridge, MA.
How do I contact Jeffrey Nau?
Verified contact routes including LinkedIn, background and funding history for Jeffrey Nau are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cambridge — who backed them, at what stage, and how much they raised.

More Biotech founders (40)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades